Last reviewed · How we verify
Biological: Fecal Microbiota Transplantation — Competitive Intelligence Brief
phase 2
Gastroenterology
Biologic
Live · refreshed every 30 min
Target snapshot
Biological: Fecal Microbiota Transplantation (Biological: Fecal Microbiota Transplantation) — Fundación GECP. Fecal Microbiota Transplantation involves transferring fecal matter from a healthy donor into a patient's gut to restore a balanced gut microbiome.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Biological: Fecal Microbiota Transplantation TARGET | Biological: Fecal Microbiota Transplantation | Fundación GECP | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Biological: Fecal Microbiota Transplantation CI watch — RSS
- Biological: Fecal Microbiota Transplantation CI watch — Atom
- Biological: Fecal Microbiota Transplantation CI watch — JSON
- Biological: Fecal Microbiota Transplantation alone — RSS
Cite this brief
Drug Landscape (2026). Biological: Fecal Microbiota Transplantation — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-fecal-microbiota-transplantation. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab